CATH Classification
| Level | CATH Code | Description | 
|---|---|---|
|   | 3 | Alpha Beta | 
|   | 3.30 | 2-Layer Sandwich | 
|   | 3.30.200 | Phosphorylase Kinase; domain 1 | 
|   | 3.30.200.20 | Phosphorylase Kinase; domain 1 | 
Domain Context
CATH Clusters
| Superfamily | Phosphorylase Kinase; domain 1 | 
| Functional Family | Hepatocyte growth factor receptor | 
Enzyme Information
| 2.7.10.1 | Receptor protein-tyrosine kinase. based on mapping to UniProt P08581 ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate. -!- The receptor protein-tyrosine kinases, which can be defined as having a transmembrane domain, are a large and diverse multigene family found only in metazoans. -!- In the human genome, 58 receptor-type protein-tyrosine kinases have been identified and these are distributed into 20 subfamilies. -!- Formerly EC 2.7.1.112. | 
UniProtKB Entries (1)
| P08581 | MET_HUMAN Homo sapiens Hepatocyte growth factor receptor | 
PDB Structure
| PDB | 5HNI | 
| External Links | |
| Method | X-RAY DIFFRACTION | 
| Organism | |
| Primary Citation | Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844). J.Med.Chem. | 
